Clinical Trial Update: DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant [Phase 4]

View source ↗

Summary

Phase 4 trial investigating direct-acting antiviral treatment in donor HCV-positive to recipient HCV-negative liver transplants; study terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease
• Hepatitis C

Snippet

Sponsor: Massachusetts General Hospital | Conditions: End Stage Liver Disease, Hepatitis C | Phase 4 | Status: TERMINATED | Results posted: 2022-07-28